NMRAL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.428600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.859600E-01
Normal-vs-Stage2
5.137200E-01
Normal-vs-Stage3
9.736600E-01
Normal-vs-Stage4
5.337200E-01
Stage1-vs-Stage2
6.444400E-01
Stage1-vs-Stage3
8.549200E-01
Stage1-vs-Stage4
9.024400E-01
Stage2-vs-Stage3
4.961400E-01
Stage2-vs-Stage4
8.186800E-01
Stage3-vs-Stage4
7.907000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.842000E-01
Normal-vs-AfricanAmerican
3.727600E-01
Normal-vs-Asian
1.620960E-01
Caucasian-vs-AfricanAmerican
4.419200E-01
Caucasian-vs-Asian
4.196100E-02
AfricanAmerican-vs-Asian
6.323400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.660600E-01
Normal-vs-Female
6.567800E-01
Male-vs-Female
2.388600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.057800E-01
Normal-vs-Age(41-60Yrs)
5.642000E-01
Normal-vs-Age(61-80Yrs)
6.039400E-01
Normal-vs-Age(81-100Yrs)
9.711900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.152000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.201800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.344600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.306200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.017700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.973800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.332200E-01
Normal-vs-Daily Drinker
2.844800E-01
Normal-vs-Weekly Drinker
2.287800E-01
Normal-vs-Occasional Drinker
5.308800E-01
Normal-vs-Social Drinker
6.635400E-01
Non Drinker-vs-Daily Drinker
9.030000E-02
Non Drinker-vs-Weekly Drinker
1.282830E-01
Non Drinker-vs-Occasional Drinker
6.287200E-01
Non Drinker-vs-Social Drinker
9.393400E-01
Daily Drinker-vs-Weekly Drinker
9.258800E-01
Daily Drinker-vs-Occasional Drinker
3.157400E-01
Daily Drinker-vs-Social Drinker
1.519810E-01
Weekly Drinker-vs-Occasional Drinker
3.737400E-01
Weekly Drinker-vs-Social Drinker
1.675600E-01
Occasional Drinker-vs-Social Drinker
6.389600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.153400E-01
Normal-vs-Grade 2
3.720200E-02
Normal-vs-Grade 3
3.576300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.816000E-02
Grade 1-vs-Grade 3
1.064440E-01
Grade 1-vs-Grade 4
2.153400E-01
Grade 2-vs-Grade 3
8.562600E-01
Grade 2-vs-Grade 4
3.720200E-02
Grade 3-vs-Grade 4
3.576300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.549800E-01
Normal-vs-NonDiabetic
3.683600E-01
Diabetic-vs-NonDiabetic
8.868400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.941900E-02
Normal-vs-NoPancreatitis
5.520400E-01
Pancreatitis-vs-NoPancreatitis
2.218300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.284800E-01
Normal-vs-N1
5.796200E-01
N0-vs-N1
6.931200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.308820E-01
Normal-vs-TP53-NonMutant
6.905200E-01
TP53-Mutant-vs-TP53-NonMutant
5.232700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
